Foghorn Therapeutics Inc (FHTX) Return on Investment ROI from the third quarter of 2026 to third quarter of 2025 and for the year 2026, average high and low, overall ranking from Sep 30 2026 to Sep 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Foghorn Therapeutics Inc   (NASDAQ: FHTX)


Foghorn Therapeutics Inc's ROI from its third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Foghorn Therapeutics Inc's ROI in the third quarter of 2026?
Foghorn Therapeutics Inc achieved a return on average invested assets (ROI) of 6.25 % in its third quarter of 2026, this is above FHTX's average return on investment of -31.34%.
Foghorn Therapeutics Inc invested over the 12 months ending in its third quarter of 2026 $151 million

ROI has improved compared to -45.41% in the second quarter of 2026, due to net income growth.

Within the Healthcare sector 295 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2026 from 3263 to 3347.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Investment Change TTM 46.91 % 117.09 % 468.75 % - -
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 154 153 158 138 120
Return On Investment (TTM) 6.25 % -45.41 % -53.38 % -50.02 % -70.33 %
FHTX's Overall Ranking # 3347 # 3263 # 3374 # 3435 #
Seq. Investment Change TTM 5.94 % 0.77 % -4.99 % 44.83 % 56.55 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions 9 -65 -75 -74 -72

FHTX Company Profile >> Back to FHTX Roi Comparisons >> See Annual FHTX Return On Investment



Return On Investment FHTX's Ranking
Within: No.
Industry # 106
Sector # 296
Overall # 3347

Return On Investment Statistics
High Average Low
-17.43 %
-31.34 %
-60.65 %
(Jun 30 2026)   (Sep 30 2020)







Financial Statements
Foghorn Therapeutics Inc's III. Quarter Investments $ 154 Millions FHTX's Balance sheet
Foghorn Therapeutics Inc's III. Quarter Income $ 58 Millions Quarterly FHTX's Income Statement
FHTX's Income by Division See FHTX's Income by Division


FHTX Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions -108 -46 -77 0 97
Y / Y Investment Growth - - - -99.85 % -59.02 %
Net Income in Millions -74 -87 -98 -109 -101
Y / Y Net Income Growth - - - - -
Annual Return On Investment - - - -77221.28 % -104.44 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
FHTX's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for FHTX's Competitors
Subscribers only: Roi for Foghorn Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for FHTX's Customers

Other Ratios
FHTX's Roa FHTX's Inventory Turnover Ratio FHTX's Growth Rates FHTX's Dividend Statistics
FHTX's Profitability Ratios FHTX's Asset Turnover Ratio FHTX's Dividend Growth
FHTX's Roe FHTX's Valuation Ratios FHTX's Financial Strength Ratios FHTX's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2026, within Healthcare Sector ROI
Healthcare Services Group Inc   17.18 %
Neurocrine Biosciences Inc   16.94 %
Krystal Biotech Inc   16.91 %
Vertex Pharmaceuticals Inc  16.63 %
Sanuwave Health Inc   16.50 %
Intuitive Surgical Inc   16.30 %
Hca Healthcare Inc   15.54 %
Kiniksa Pharmaceuticals International Plc  15.45 %
Amgen Inc   13.64 %
Carlisle Companies Incorporated  13.64 %
Bristol myers Squibb Company  13.59 %
3m Company  13.24 %
Alpha Pro Tech Ltd   13.18 %
Beone Medicines Ltd   13.17 %
Regeneron Pharmaceuticals Inc   13.00 %
Abbvie Inc   12.87 %
Lantheus Holdings Inc   11.96 %
Msa Safety Inc  11.78 %
Inspire Medical Systems inc   11.63 %
Transmedics Group Inc   11.55 %
Bioventus Inc   11.26 %
Tenet Healthcare Corp  10.91 %
Bio rad Laboratories Inc   10.59 %
Lemaitre Vascular Inc   10.56 %
Johnson and Johnson  10.53 %
Encompass Health Corporation  10.41 %
Ani Pharmaceuticals Inc  9.61 %
Tactile Systems Technology Inc   9.27 %
Boston Scientific Corporation  9.14 %
Brightspring Health Services Inc   9.01 %

Date modified: 2026-11-10T06:11:21+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.